


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+0.39%
+24.05%
+1.04%
-8.58%
+2.33%
HCA
HCA Healthcare
$471.65
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
Chart
$418.87 (+12.60%)
$390.46 (+20.79%)
$368.59 (+27.96%)
$335.11 (+40.74%)
HCA has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

HCA overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings

Earnings increase YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
HCA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
HCA Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is HCA current stock price?
What are HCA stock strengths?
What risks are associated with HCA stock?
When is HCA next earnings report?
What is HCA market cap and volume?
What is HCA's current Stock IQ?
Should I buy HCA stock right now?
Is HCA a Strong Buy right now?
What does a 'Strong Buy' rating mean for HCA?
What does a 'Strong Sell' rating mean for HCA?
What factors influence HCA's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+0.39%
+24.05%
+1.04%
-8.58%
+2.33%
HCA
HCA Healthcare
Current Price
$471.65
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Chart
$418.87 (+12.60%)
$390.46 (+20.79%)
$368.59 (+27.96%)
$335.11 (+40.74%)
HCA Analysts Opinion
HCA Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings

Earnings increase YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
HCA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
HCA Street view is extremely bullish and have positive views on the near-term outlook
HCA has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels.
HCA Latest Analysis
Heres Why HCA Healthcare (HCA) is a Strong Growth Stock. Wondering how to pick strong market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Thu Oct 30, 2025
Why HCA Healthcare (HCA) is a Top Stock for the Long-Term. The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Heres why you should take advantage.
Wed Oct 29, 2025
HCA Healthcare Inc. (HCA) Hit a 52 Week High Can the Run Continue?. HCA (HCA) is at a 52-week high but can investors hope for more gains in the future? We take a look at the companys fundamentals for clues.
Tue Oct 28, 2025
HCA Healthcare Analysts Increase Their Forecasts After Upbeat Q3 Earnings. HCA) posted upbeat third-quarter 2025 financial results on Friday.HCA reported total revenues of $19.16 billion representing a 9.6% year-over-year increase surpassing the consensus estimate of $18.57 billion. The hospital chain reported adjusted earnings of $6.96 up from $4.90 a year ago surpassing the consensus of $5.72.“.Our teams continued to execute our agenda at a high level and we remain disciplined in our effo
Mon Oct 27, 2025
HCA Healthcare raises 2025 EPS guidance to $27-$28 while advancing $5B capital spending and resiliency initiatives.
Fri Oct 24, 2025
HCA Q3 Earnings Beat Estimates on Rising Inpatient Surgery Cases. HCA Healthcares Q3 earnings rise 42% y/y on stronger patient volumes and rising inpatient surgeries prompting management to lift its 2025 outlook.
Fri Oct 24, 2025
HCA Healthcare declares $0.72 dividend.
Fri Oct 24, 2025
HCA Healthcare (HCA) Q3 Earnings and Revenues Top Estimates. HCA (HCA) delivered earnings and revenue surprises of 23.19% and 3.55% respectively for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Fri Oct 24, 2025
HCA Healthcare Inc. Q3 Income Climbs Beats Estimates . (RTTNews) - HCA Healthcare Inc. (HCA) released a profit for its third quarter that Increased from last year and beat the Street estimates.
Fri Oct 24, 2025
HCA Healthcare Raises 2025 Guidance . (RTTNews) - HCA Healthcare (HCA) said for 2025 the company now expects EPS in a range of $27.00 to $28.00 updated from prior guidance range of $25.50 to $27.00. Revenues are now projected in a range of $75.0 to $76.5 billion revised from previous outlook range of $74.0 to $76
Fri Oct 24, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.